T652-0215 Screening compound: [3-(4-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl][4-(2-pyrimidinyl)piperazino]methanone

T652-0215 Screening compound: [3-(4-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl][4-(2-pyrimidinyl)piperazino]methanone
T652-0215 Screening compound: [3-(4-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl][4-(2-pyrimidinyl)piperazino]methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound T652-0215
[3-(4-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl][4-(2-pyrimidinyl)piperazino]methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T652-0215

Molecular Formula

C23H26N6O2 (C23 H26 N6 O2)

Compound Name

[3-(4-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl][4-(2-pyrimidinyl)piperazino]methanone

IUPAC name

2-{4-[3-(4-methoxyphenyl)-5H6H7H8H-imidazo[12-a]pyridine-6-carbonyl]piperazin-1-yl}pyrimidine

SMILES

COc(cc1)ccc1-c1cnc(CC2)n1CC2C(N(CC1)CCN1c1ncccn1)=O

InChI

InChI=1S/C23H26N6O2/c1-31-19-6-3-17(4-7-19)20-15-26-21-8-5-18(16-29(20)21)22(30)27-11-13-28(14-12-27)23-24-9-2-10-25-23/h2-4,6-7,9-10,15,18H,5,8,11-14,16H2,1H3/t18-/m0/s1

InChI Key

NPMBTOPVUSIZQE-SFHVURJKSA-N

MDL Number (MFCD)

MFCD29002410

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

418.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.023

Distribution Coefficient, logD

2.133

Water Solubility, LogSw

-2.86

Polar Surface Area

57.202

Acid Dissociation Constant (pKa)

21.15

Base Dissociation Constant (pKb)

8.23

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.13

T652-0215 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Akt-Targeted Library (14764 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Cyclic compounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with T652-0215 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T652-0215?
Check Price and Availability of T652-0215, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T652-0215 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T652-0215
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T652-0215
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T652-0215 available by request